Cytokinetics Incorporated – Credit Agreements

NASDAQ: CYTK
Share price (8/10/26): $77.49
Market cap (8/10/26): $10.8 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Credit Agreements Filter

from 10-Q 49 pages 2024 Development Funding Loan Agreement Article 1 Accounting and Other Terms

from 10-K 52 pages Development Funding Loan Agreement

from 10-Q 4 pages Fourth Amendment to Loan and Security Agreement

from 10-Q 6 pages Third Amendment to Loan and Security Agreement

from 8-K 4 pages Second Amendment to Loan and Security Agreement

from 8-K 9 pages First Amendment to Loan and Security Agreement

from 10-Q 83 pages Loan and Security Agreement

from 10-K 34 pages Second Amendment to Loan and Security Agreement

from 10-K 113 pages Loan and Security Agreement

from 8-K ~5 pages May 15, 2007 Revised: June 19, 2007 Revised: August 10, 2007 Revised: August 24, 2007 Confidential Loan Proposal For: Cytokinetics, Inc. Submitted By: Barbara Kaiser 1

from 8-K 9 pages 1st Revision (Changes Underlined) Confidential Loan Proposal For: Cytokinetics, Inc. Submitted By: Todd Cortell Cytokinetics, Inc